1. Home
  2. ANSC vs AMLX Comparison

ANSC vs AMLX Comparison

Compare ANSC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANSC
  • AMLX
  • Stock Information
  • Founded
  • ANSC 2021
  • AMLX 2014
  • Country
  • ANSC United States
  • AMLX United States
  • Employees
  • ANSC N/A
  • AMLX N/A
  • Industry
  • ANSC
  • AMLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANSC
  • AMLX Health Care
  • Exchange
  • ANSC Nasdaq
  • AMLX Nasdaq
  • Market Cap
  • ANSC 463.6M
  • AMLX 459.1M
  • IPO Year
  • ANSC 2023
  • AMLX 2022
  • Fundamental
  • Price
  • ANSC $10.81
  • AMLX $6.32
  • Analyst Decision
  • ANSC
  • AMLX Strong Buy
  • Analyst Count
  • ANSC 0
  • AMLX 7
  • Target Price
  • ANSC N/A
  • AMLX $11.14
  • AVG Volume (30 Days)
  • ANSC 40.9K
  • AMLX 1.0M
  • Earning Date
  • ANSC 01-01-0001
  • AMLX 08-07-2025
  • Dividend Yield
  • ANSC N/A
  • AMLX N/A
  • EPS Growth
  • ANSC N/A
  • AMLX N/A
  • EPS
  • ANSC 0.19
  • AMLX N/A
  • Revenue
  • ANSC N/A
  • AMLX N/A
  • Revenue This Year
  • ANSC N/A
  • AMLX N/A
  • Revenue Next Year
  • ANSC N/A
  • AMLX N/A
  • P/E Ratio
  • ANSC $56.59
  • AMLX N/A
  • Revenue Growth
  • ANSC N/A
  • AMLX N/A
  • 52 Week Low
  • ANSC $10.23
  • AMLX $1.62
  • 52 Week High
  • ANSC $10.93
  • AMLX $7.27
  • Technical
  • Relative Strength Index (RSI)
  • ANSC 67.55
  • AMLX 67.39
  • Support Level
  • ANSC $10.81
  • AMLX $4.80
  • Resistance Level
  • ANSC $10.89
  • AMLX $6.70
  • Average True Range (ATR)
  • ANSC 0.03
  • AMLX 0.42
  • MACD
  • ANSC 0.00
  • AMLX 0.09
  • Stochastic Oscillator
  • ANSC 47.83
  • AMLX 83.68

About ANSC Agriculture & Natural Solutions Acquisition Corporation

Agriculture & Natural Solutions Acquisition Corp is a blank check company.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: